Literature DB >> 11819223

Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma.

Zhuo-Lin Deng, Yun Ma.   

Abstract

AIM:To study the p53 gene mutation and its relationship to aflatoxin B1 exposure in hepatocellular carcinoma (HCC).
METHODS: Restriction fragment length polymorphism analysis method was used in 62 HCC samples, and DNA direct sequencing in another 45 HCC samples.
RESULTS: In HCC and AFB1 high and low-risk areas, 36/52 (69%) and 2/10 (20%) cases were found losing the HaeIII allele respectively, suggesting one of the base G mutation at the p53 gene codon 249. Similar results appeared in DNA direct sequencing, 20/35 (57%) and 1/10 (10%) respectively mutated at the codon 249 third base G to C transversion.
CONCLUSION: In HCC after AFB1 exposure, mutation of p53 gene is fixed at codon 249 third base and take the form of G to T transversion. This is a definite marker of mutation which is induced by AFB1 mutagen. It is applicable for molecular epidemiologic survey of the sufferers of AFB1 among HCC cases and for discovering more unknown natural AFB1 contaminated areas.

Entities:  

Year:  1998        PMID: 11819223      PMCID: PMC4767757          DOI: 10.3748/wjg.v4.i1.28

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  p53 mutation in hepatocellular carcinoma after aflatoxin exposure.

Authors:  M Ozturk
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

2.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

3.  Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.

Authors:  F S Yeh; M C Yu; C C Mo; S Luo; M J Tong; B E Henderson
Journal:  Cancer Res       Date:  1989-05-01       Impact factor: 12.701

4.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

5.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

6.  Aberrations of p53 gene in human hepatocellular carcinoma from China.

Authors:  D Li; Y Cao; L He; N J Wang; J R Gu
Journal:  Carcinogenesis       Date:  1993-02       Impact factor: 4.944

7.  p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.

Authors:  K A Scorsone; Y Z Zhou; J S Butel; B L Slagle
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

8.  Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.

Authors:  Y Fujimoto; L L Hampton; P J Wirth; N J Wang; J P Xie; S S Thorgeirsson
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

  8 in total
  19 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

5.  Identification of antigens by monoclonal antibody PD4 and its expression in Escherichia coli.

Authors:  Jin-Ying Ning; Guo-Xun Sun; Su Huang; Hong Ma; Ping An; Lin Meng; Shu-Mei Song; Jian Wu; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 6.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

7.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

8.  Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus.

Authors:  S P Guo; W L Wang; Y Q Zhai; Y L Zhao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

9.  Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China.

Authors:  Zhuo-Lin Deng; Yi-Ping Wei; Yun Ma
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

10.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.